Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure

Genes and Development

Volumn 10, Issue 2, 1996, Pages 196-207

  Doucas, Vassilis ^a   Ishov, Alexander M ^b   Romo, Anthony ^a   Juguilon, Henry ^a,c   Weitzman, Matthew D ^c   Evans, Ronald M ^a,c   Maul, Gerd G ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b WISTAR INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

adenovirus replication; nuclear organization; PML; POD; Sp 100

Indexed keywords

AUTOANTIGEN; BROXURIDINE; DNA BINDING PROTEIN; INTERFERON; NUCLEAR PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL INCLUSION; CELL NUCLEUS; CELL NUCLEUS MATRIX; CONTROLLED STUDY; DNA TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; VIRUS MUTANT; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0030052130     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.2.196     Document Type: Article

References (70)

1. Akusjarvi, G. 1993. Proteins with transcription regulatory properties encoded by human adenoviruses. Trends Microbiol. 1: 163-170.
2. Ascoli, C.A. and G.G. Maul. 1991. Identification of a novel nuclear domain. J. Cell Biol. 112: 785-795.
3. Babiss, L.E and H.S. Ginsberg. 1984. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50: 202-212.
4. Bargonetti, J., I. Reynisdottir, P.N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes & Dev. 6: 1886-1898.
5. Berezney, R. and D.S. Coffey. 1976. The nuclear protein matrix: Isolation, structure, and functions. Adv. Enzyme Regul. 14: 63-100.
6. Berk, A.J. 1986. Adenovirus promoters and E1A transactivation. Annu Rev. Genet, 20: 45-79.
7. Berk, A.J. and P.A. Sharp. 1978. Structure of the adenovirus 2 early mRNAs. Cell 14: 695-711.
8. Berkner, K.L. 1992. Expression of heterologous sequences in adenoviral vectors. Curr. Top Microbiol. Immunol. 158: 39-66.
9. Bosher, J., A. Dawson, and R.T. Hay. 1992. Nuclear factor I is specifically targeted to discrete subnuclear sites in adenovirus type 2-infected cells. J. Virol. 66: 3140-3150.
10. Bridge, E. and G. Ketner. 1989. Redundant control of adenovirus late gene expression by early region 4. J. Virol. 63: 631-638.
11. Brough, D.E., V. Cleghon, and D.F. Klessig. 1992. Construction, characterization, and utilization of cell lines which inducibly express the adenovirus DNA-binding protein. Virology 190: 624-634.
12. Castaigne, S , C. Chomienne, M.T. Daniel, P. Ballerini, R. Berger, P. Penaux, and L. Degos. 1990. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. J Clinical results [see comments]. Blood 76: 1704-1709.
13. Chang, K.S., S.A Stass, D.T. Chu, L.L. Deaven, J.M. Trujillo, and E.J. Freireich. 1992. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol. Cell Biol. 12: 800-810.
14. Cutt, J.R., T. Shenk, and P. Hearing. 1987. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J. Virol 61: 543-552.
15. de Thé, H., C. Lavau, A. Marchio, C. Chomienne, L. Degos, and A. Dejean. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675-684.
16. Doucas, V., J.P. Brockes, M. Yaniv, H. de Thé, and A. Dejean. 1993. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. Proc. Natl. Acad. Sci. 90: 9345-9349.
17. Dyck, I.A., G.G. Maul, W. Miller Jr., J.D. Chen, A. Kakizuka, and R.M. Evans. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333-343.
18. Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell 58: 249-255.
19. Freemont, P.S., I.M. Hanson and J. Trowsdale. 1991. A novel cysteine-rich sequence motif [Letter]. Cell 64: 483-484.
20. Freyer, G.A., Y. Katoh, and R.J. Roberts. 1984. Characterization of the major mRNAs from adenovirus 2 early region 4 by cDNA cloning and sequencing. Nucleic Acids Res. 12: 3503-3519.
21. Goddard, A.D., J. Borrow, and E. Solomon. 1992. A previously uncharacterized gene, PML, is fused to the retinoic acid receptor alpha gene in acute promyelocytic leukaemia. Leukemia 6: 117S-119S.
22. Graham, F.L., J. Smiley, W.C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36: 59-74.
23. Grignani, F., P.P. Ferrucci, U. Testa, G. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, F. Grignani, C. Peschle, I. Nicoletti, et al. 1993. The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74: 423-431.
24. Guldner, H.H., C. Szostecki, T. Grotzinger, and H. Will. 1992. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149: 4067-4073.
25. Halbert, D.N., J.R. Cutt, and T. Shenk. 1985. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol 56: 250-257.
26. Herisse, J., M. Rigolet, S.D. de Dinechin, and F. Galibert. 1981. Nucleotide sequence of adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the entire E4 region. Nucleic Acids Res. 9: 4023-4042.
27. Huang, M.E., Y.C. Ye, S.R. Chen, J.R. Chai, J.X. Lu, L. Zhoa, L.J. Gu, and Z.Y. Wang. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572.
28. Huang, M.M. and P. Hearing. 1989. Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J. Virol. 63: 2605-2615.
29. Jimenez-Garcia, L.F. and D.L. Spector. 1993. In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell 73: 47-59.
30. Jones, N. and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
31. Kakizuka, A., W. Miller Jr., K. Umesono, R. Warrell Jr., S.R Frankel, V.V. Murty, E. Dmitrovsky, and R.M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663-674.
32. Kastner, P., A. Perez, Y. Lutz, C. Rochette-Egly, M.P. Gaub, B. Durand, M. Lanotte, R. Berger, and P. Chambon. 1992. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J. 11: 629-642.
33. Kenny, M.K., L.A. Balogh, and J. Hurwitz. 1988 Initiation of adenovirus DNA replication. I. Mechanism of action of a host protein required for replication of adenovirus DNA templates devoid of the terminal protein. J. Biol. Chem. 263: 9801-9808.
34. Khittoo, G , L. Delorme, C.V. Dery, M.L. Tremblay, J.M. Weber, V. Bibor-Hardy, and R. Simard. 1986. Role of the nuclear matrix in adenovirus maturation. Virus Res. 4: 391-403.
35. Koken, M.H., F. Puvion-Dutilleul, M.C. Guillemin, A. Viron, G. Linares-Cruz, N. Stuurman, L. de Jong, C. Szostecki, F. Calvo, C. Chomienne, et al. 1994. The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13: 1073-1083.
36. Kozarsky, K., M. Grossman, and J.M. Wilson. 1993. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somat. Cell Mol. Genet. 19: 449-458.
37. Levine, A.J. 1984. The adenovirus early proteins. Curr. Top. Microbiol. Immunol. 110: 143-167.
38. Mariman, E.C , C.A. van Eekelen, R.J. Reinders, A.J. Berns, and W.J. van Venrooij. 1982. Adenoviral heterogeneous nuclear RNA is associated with the host nuclear matrix during splicing. J. Mol. Biol 154: 103-119.
39. Maul, G.G., E. Yu, A.M. Ishov, and A.L. Epstein. 1995. Nuclear domain 10 (ND10) associated proteins are present in nuclear bodies and redistributed to hundreds of nuclear sites after stress. J. Cell Biochem. 59: 499-514.
40. Mitelman, F. 1988. Catalog of chromosome aberrations in cancer, 3rd ed. Allen Liss, New York.
41. Mul, Y.M., C.P. Verrijzer, and P.C. van der Vliet. 1990. Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication. J. Virol 64: 5510-5518.
42. Nevins, J.R. 1987. Regulation of early adenovirus gene expression. Microbiol. Rev. 51: 419-430.
43. Niman, H.L., R.A. Houghten, L.E. Walker, R.A. Reisfeld, I.A. Wilson, J.M. Hogle, and R.A. Lerner. 1983 Generation of protein-reactive antibodies by short peptides is an event of high frequency: Implications for the structural basis of immune recognition. Proc. Natl. Acad. Sci. 80: 4949-4953.
44. Obert, S., R.J. O'Connor, S. Schmid, and P. Hearing. 1994. The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex. Mol. Cell Biol. 14: 1333-1346.
45. Ornelles, D.A. and T. Shenk. 1991. Localization of the adenovirus early region IB 55-kilodalton protein during lytic infection: Association with nuclear viral inclusions requires the early region 4 34-kilodalton protein. J. Virol. 65: 424-429.
46. Pandolfi, P.P., F. Grignani, M. Alcalay, A. Mencarelli, A. Biondi, F. LoCoco, F. Grignani, and P.G. Pelicci. 1991. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6: 1285-1292.
47. Perez, A., P. Kastner, S. Sethi, Y. Lutz, C. Reibel, and P. Chambon. 1993. PMLRAR homodimers: Distinct DNA binding properties and heteromeric interactions with RXR. EMBO J. 12: 3171-3182.
48. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenovirus E1B-S5K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol. 6: 470-476.
49. Pombo, A., J. Ferreira, E. Bridge, and M. Carmo-Fonseca. 1994. Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J. 13: 5075-5085.
50. Puvion-Dutilleul, F., R. Roussev, and E. Puvion. 1992. Distribution of viral RNA molecules during the adenovirus type 5 infectious cycle in HeLa cells. J. Struct. Biol. 108: 209-220.
51. Reich, N.C., P. Samow, E. Duprey, and A.J. Levine. 1983. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNA-binding protein. Virology 128: 480-484.
52. Rice, S.A. and D.F. Klessig. 1985. Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein. J. Virol. 56: 767-778.
53. Sarnow, P., Y.S. Ho, J. Williams, and A.J. Levine 1982a. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28: 387-394.
54. Sarnow, P., P. Hearing, C.W. Anderson, N. Reich, and A.J. Levine. 1982b. Identification and characterization of an immunologically conserved adenovirus early region 11,000 Mr protein and its association with the nuclear matrix. J. Mol. Biol 162: 565-583.
55. Sarnow, P., C.A. Sullivan, and A.J. Levine. 1982c. A monoclonal antibody detecting the adenovirus type 5-E1b-58Kd tumor antigen: Characterization of the Elb-58Kd tumor antigen in adenovirus-infected and -transformed cells. Virology 120: 510-517.
56. Sarnow, P., P. Hearing, C.W. Anderson, D.N. Halbert, T. Shenk, and A.J. Levine. 1984. Adenovirus early region IB 58,000-dalton tumor antigen is physically associated with an early region 4 25,000-dalton protein in productively infected cells. J. Virol. 49: 692-700.
57. Schaack, J., W.Y. Ho, P. Freimuth, and T. Shenk. 1990. Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA. Genes & Dev. 4: 1197-1208.
58. Schneider, R.J. and T. Shenk. 1987. Impact of virus infection on host cell protein synthesis. Annu. Rev. Biochem. 56: 317-332.
59. Shirodkar, S., M. Ewen, J.A. DeCaprio, J. Morgan, D.M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157-166.
60. Stuurman, N., A. de Graaf, A. Floore, A. Josso, B. Humbel, L. de Jong, and R. van Driel. 1992. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101: 773-784.
61. Tigges, M A. and H.J. Raskas. 1984. Splice junctions in adenovirus 2 early region 4 mRNAs: Multiple splice sites produce 18 to 24 RNAs. J. Virol. 50: 106-117.
62. Virtanen, A., P. Gilardi, A. Naslund, J.M. LeMoullec, U. Pettersson, and M. Perricaudet. 1984. mRNAs from human adenovirus 2 early region 4. J. Virol 51: 822-831.
63. Weiden, M.D. and H.S. Ginsberg. 1994. Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc. Natl. Acad. Sci. 91: 153-157
64. Weinberg, D.H. and G. Kectner. 1983. A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc. Natl. Acad Sci. 80: 5383-5386.
65. _. 1986. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J. Virol. 57: 833-838.
66. Weis, K., S. Rambaud, C. Lavau, J. Jansen, T. Carvalho, M. Carmo-Fonseca, A. Lamond, and A. Dejean. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76: 345-356.
67. Wigler, M., S. Silverstein, L.S. Lee, A. Pellicer, Y. Cheng, and R. Axel. 1977. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11: 223-232.
68. Yew, P.R., X. Liu, and A.J. Berk. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes & Dev. 8: 190-202.
69. Younghusband, H.B. and K. Maundrell. 1982. Adenovirus DNA is associated with the nuclear matrix of infected cells. J. Virol. 43: 705-713.
70. Zhai, Z.H., J.A. Nickerson, G. Krochmalnic, and S. Penman. 1987. Alterations in nuclear matrix structure after adenovirus infection. J. Virol. 61: 1007-1018.